Insights

Innomar Strategies

Insight Series: The Value of Real-World Evidence in Canadian Drug Commercialization – Part 1

Innomar Strategies

January 2019

Innomar Strategies

InnomarLive Summary: Healthcare Innovation

Innomar Strategies

December 2018

Innomar Strategies

Insight Series: Value of Patient Support Programs for Specialty Medications in Canada

Innomar Strategies

May 2018

Innomar Strategies

Infographic: The Route to Market Access in Canada

Innomar Strategies

May 2018

Innomar Strategies

Infographic: The Road to Commercialization in Canada

Innomar Strategies

May 2018

Innomar Strategies

Insight Series: Biosimilars in Canada

Innomar Strategies

January 2018

Innomar Strategies

Drug Reimbursement in Canada

Innomar Strategies

September 2017

Innomar Strategies

Improved Health Outcomes in Patients Receiving Health Case Management

Innomar Strategies

April 2017

Innomar Strategies

Understanding the Journey of a Person with a Rare Disease

Innomar Strategies

February 2017

Innomar Strategies

Specialty pharmacies enhance patient outcomes [Pharmacy Practice Plus]

Jason Zabransky

January 2017

Innomar Strategies

Case Study: Patient-centric Care in Rare Disease

Innomar Strategies

July 2016

Innomar Strategies

Future of Patient Support Programs in Canada

Sandra Anderson

June 2016

Innomar Strategies

Case Study: Optimizing a Patient Support Program to Improve Therapy Adherence

Innomar Strategies

April 2015

Innomar Strategies

Case Study: Leveraging Physician Relationships to Co-create Patient Support

Innomar Strategies

April 2015

Innomar Strategies

Case Study: Discovering New Opportunities for Growth in a Niche Market

Innomar Strategies

April 2015

Innomar Strategies

Support Programs Designed to Assist Patients and Their Families

Sandra Anderson

March 2014

Innomar Strategies

Nurse-led Health Case Management

Innomar Strategies

Innomar Strategies

Big Wins in Record Time for Gaining Market Access with Phase II Data

Innomar Strategies

Insights

Insight Series: The Value of Real-World Evidence in Canadian Drug Commercialization – Part 1

InnomarLive Summary: Healthcare Innovation

Insight Series: Value of Patient Support Programs for Specialty Medications in Canada

Infographic: The Route to Market Access in Canada

Infographic: The Road to Commercialization in Canada

Insight Series: Biosimilars in Canada

Drug Reimbursement in Canada

Improved Health Outcomes in Patients Receiving Health Case Management

Understanding the Journey of a Person with a Rare Disease

Specialty pharmacies enhance patient outcomes [Pharmacy Practice Plus]

Case Study: Patient-centric Care in Rare Disease

Future of Patient Support Programs in Canada

Case Study: Optimizing a Patient Support Program to Improve Therapy Adherence

Case Study: Leveraging Physician Relationships to Co-create Patient Support

Case Study: Discovering New Opportunities for Growth in a Niche Market

Support Programs Designed to Assist Patients and Their Families

Nurse-led Health Case Management

Big Wins in Record Time for Gaining Market Access with Phase II Data

Explore More by Topic

Affordability

Analytics

Biosimilars

Commercialization

Data

Legislation